Index S&P 500
P/E 50.72
EPS (ttm) 7.56
Insider Own 6.32%
Shs Outstand 382.30M
Perf Week -2.29%
Market Cap 146.55B
Forward P/E 25.59
EPS next Y 14.98
Insider Trans -1.64%
Shs Float 358.13M
Perf Month 1.16%
Enterprise Value 161.22B
PEG 4.55
EPS next Q 3.14
Inst Own 81.36%
Short Float 1.17%
Perf Quarter 0.75%
Income 2.92B
P/S 6.15
EPS this Y 10.69%
Inst Trans 0.31%
Short Ratio 3.44
Perf Half Y 5.41%
Sales 23.82B
P/B 6.92
EPS next Y 11.02%
ROA 6.83%
Short Interest 4.19M
Perf YTD 6.47%
Book/sh 55.43
P/C 59.48
EPS next 5Y 11.14%
ROE 14.25%
52W High 406.19 -5.63%
Perf Year 5.01%
Cash/sh 6.45
P/FCF 36.42
EPS past 3/5Y 14.17% 7.20%
ROIC 8.01%
52W Low 329.16 16.46%
Perf 3Y 81.50%
Dividend Est. 3.23 (0.84%)
EV/EBITDA 24.76
Sales past 3/5Y 9.72% 8.71%
Gross Margin 62.19%
Volatility 1.76% 1.61%
Perf 5Y 93.98%
Dividend TTM 3.32 (0.87%)
EV/Sales 6.77
EPS Y/Y TTM -15.66%
Oper. Margin 22.72%
ATR (14) 6.56
Perf 10Y 296.50%
Dividend Ex-Date Sep 30, 2025
Quick Ratio 1.06
Sales Y/Y TTM 11.36%
Profit Margin 12.25%
RSI (14) 44.63
Recom 1.69
Dividend Gr. 3/5Y 7.89% 8.75%
Current Ratio 1.78
EPS Q/Q 6.88%
SMA20 -1.58%
Beta 0.97
Target Price 439.56
Payout 41.74%
Debt/Eq 0.81
Sales Q/Q 11.07%
SMA50 -1.47%
Rel Volume 0.81
Prev Close 388.79
Employees 53000
LT Debt/Eq 0.72
Earnings Jul 31 AMC
SMA200 0.80%
Avg Volume 1.22M
Price 383.34
IPO Mar 17, 1980
Option/Short Yes / Yes
EPS/Sales Surpr. 2.00% 1.45%
Trades
Volume 985,297
Change -1.40%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-25 Resumed
Citigroup
Buy
$450
Dec-02-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$370 → $445
Sep-10-24 Initiated
Wolfe Research
Outperform
$405
May-30-24 Initiated
Goldman
Neutral
$372
May-22-24 Upgrade
Needham
Hold → Buy
$392
Jan-31-24 Upgrade
Canaccord Genuity
Hold → Buy
$315 → $360
Oct-20-23 Initiated
ROTH MKM
Buy
$345
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Show Previous Ratings
Sep-09-25 07:20AM
Sep-02-25 11:40AM
08:54AM
Sep-01-25 12:11PM
Aug-28-25 09:40AM
11:36PM
Loading…
Aug-27-25 11:36PM
Aug-22-25 09:53AM
Aug-20-25 11:27AM
Aug-19-25 01:21PM
05:59AM
Aug-18-25 12:00PM
Aug-15-25 11:40AM
08:00AM
Aug-14-25 08:00AM
Aug-13-25 03:50PM
08:51AM
Loading…
08:51AM
06:27AM
Aug-12-25 11:50PM
11:39PM
12:30PM
10:44AM
08:14AM
Aug-11-25 05:29AM
Aug-08-25 01:17PM
12:03AM
Aug-07-25 02:20PM
08:00AM
Aug-05-25 09:40AM
07:35AM
Aug-01-25 02:00PM
09:38AM
Loading…
09:38AM
(The Wall Street Journal)
09:24AM
09:03AM
08:50AM
07:57AM
07:42AM
03:35AM
Jul-31-25 06:01PM
05:20PM
05:05PM
05:00PM
(The Wall Street Journal)
04:22PM
(Associated Press Finance)
04:05PM
Jul-30-25 07:30AM
Jul-29-25 11:13PM
09:07AM
08:54AM
04:38AM
Jul-28-25 11:40AM
06:00AM
02:08AM
Jul-24-25 10:00AM
Jul-23-25 09:45AM
04:30AM
[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
(GlobeNewswire)
Jul-22-25 08:30AM
07:30AM
07:22AM
Jul-18-25 07:02AM
Jul-16-25 10:15AM
(Investor's Business Daily)
Jul-15-25 09:47AM
Jul-14-25 10:00AM
08:22AM
Jul-11-25 09:46AM
05:07AM
Jul-10-25 09:28AM
07:53AM
Jul-09-25 11:10AM
Jul-08-25 08:26AM
Jul-07-25 04:49PM
11:40AM
09:30AM
08:48AM
Jul-04-25 04:19AM
03:23AM
Jul-01-25 08:00AM
Jun-30-25 08:30AM
Jun-27-25 05:32AM
Jun-26-25 09:40AM
05:12AM
Jun-25-25 08:15AM
08:13AM
01:30AM
Jun-24-25 08:27AM
Jun-18-25 07:34AM
Jun-16-25 12:04AM
Jun-13-25 08:19AM
Jun-11-25 05:00AM
Jun-06-25 06:02AM
Jun-05-25 01:59PM
09:37AM
Jun-04-25 11:30AM
May-30-25 11:40AM
May-27-25 05:57PM
May-22-25 11:58AM
May-20-25 09:22AM
May-19-25 01:01PM
May-16-25 06:39AM
May-14-25 05:42AM
May-10-25 04:10AM
May-09-25 07:47AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Menon Viju Group President Aug 25 '25 Sale 390.61 500 195,305 12,511 Aug 27 04:32 PM Viju Menon Officer Aug 25 '25 Proposed Sale 390.61 500 195,305 Aug 25 12:17 PM Fletcher Robert S VP, Chief Legal Officer Aug 20 '25 Sale 393.07 1,785 701,630 10,457 Aug 21 04:06 PM Robert Fletcher Officer Aug 20 '25 Proposed Sale 393.06 1,785 701,620 Aug 20 04:05 PM STRYKER RONDA E Director Aug 06 '25 Sale 376.45 200,000 75,289,655 3,222,108 Aug 07 04:36 PM Berry William E Jr VP, Chief Accounting Officer May 12 '25 Sale 388.56 1,241 482,202 2,833 May 14 04:05 PM William Berry Jr Officer May 12 '25 Proposed Sale 388.56 1,241 482,197 May 12 04:18 PM Allan Golston Director May 12 '25 Proposed Sale 390.06 6,101 2,379,738 May 12 11:10 AM Allan Golston Director May 09 '25 Proposed Sale 383.67 4,184 1,605,264 May 09 11:49 AM STRYKER RONDA E Director May 06 '25 Sale 376.96 200,000 75,391,848 3,417,326 May 08 04:58 PM Glenn Boehnlein Officer May 07 '25 Proposed Sale 383.09 9,000 3,447,803 May 07 04:03 PM Stiles Spencer S Group President Mar 21 '25 Option Exercise 0.00 314 0 68,603 Mar 25 04:45 PM Pierce James Andrew Group President Mar 21 '25 Option Exercise 0.00 314 0 72,561 Mar 25 04:41 PM Menon Viju Group President Mar 21 '25 Option Exercise 0.00 187 0 16,934 Mar 25 04:37 PM Lobo Kevin Chair and CEO Mar 21 '25 Option Exercise 0.00 1,085 0 145,625 Mar 25 04:32 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 '25 Option Exercise 0.00 144 0 15,261 Mar 25 04:28 PM Fink M Kathryn VP, Chief HR Officer Mar 21 '25 Option Exercise 0.00 102 0 14,157 Mar 25 04:24 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 '25 Option Exercise 0.00 314 0 18,358 Mar 25 04:20 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 '25 Option Exercise 0.00 42 0 34,586 Mar 25 04:11 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 27 '25 Option Exercise 96.64 4,980 481,267 35,729 Feb 27 06:15 PM Golston Allan C. Director Feb 18 '25 Option Exercise 122.51 3,605 441,649 18,500 Feb 19 08:46 PM Golston Allan C. Director Feb 18 '25 Sale 383.07 2,458 941,586 14,895 Feb 19 08:46 PM Allan Golston Director Feb 18 '25 Proposed Sale 382.83 2,458 941,000 Feb 18 03:15 PM Silvernail Andrew K Director Feb 03 '25 Option Exercise 93.06 3,795 353,163 14,705 Feb 04 04:27 PM STRYKER RONDA E Director Jan 30 '25 Option Exercise 93.06 3,795 353,163 7,735 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Sale 392.24 201,392 78,993,068 3,642,075 Feb 03 04:44 PM STRYKER RONDA E Director Jan 31 '25 Proposed Sale 389.92 236,000 92,020,000 Feb 03 08:58 AM Stiles Spencer S Group President Jan 29 '25 Option Exercise 93.06 10,210 950,143 60,821 Jan 30 04:45 PM Pierce James Andrew Group President Jan 29 '25 Option Exercise 93.06 9,455 879,882 64,868 Jan 30 04:38 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 31 '24 Option Exercise 122.51 300 36,753 5,331 Jan 02 04:44 PM Boehnlein Glenn S VP, Chief Financial Officer Dec 27 '24 Option Exercise 122.51 2,000 245,020 6,373 Dec 30 04:19 PM Boehnlein Glenn S VP, Chief Financial Officer Nov 18 '24 Option Exercise 122.51 4,500 551,295 7,352 Nov 19 04:36 PM Stiles Spencer S Group President Nov 15 '24 Sale 391.16 514 201,056 50,611 Nov 18 04:58 PM Stiles Spencer S Officer Nov 15 '24 Proposed Sale 389.88 514 200,398 Nov 15 11:39 AM Lobo Kevin Chair and CEO Nov 07 '24 Option Exercise 93.06 156,890 14,600,183 256,917 Nov 08 04:20 PM Lobo Kevin Chair and CEO Nov 07 '24 Sale 368.70 57,313 21,131,479 100,027 Nov 08 04:20 PM Kevin Lobo Officer Nov 07 '24 Proposed Sale 368.15 57,313 21,100,000 Nov 07 04:43 PM STRYKER RONDA E Director Nov 05 '24 Sale 367.37 230,000 84,494,990 3,086,608 Nov 07 04:33 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 05 '24 Option Exercise 96.64 4,980 481,267 33,938 Nov 05 06:13 PM STRYKER RONDA E Director Nov 05 '24 Proposed Sale 365.00 230,000 83,950,000 Nov 05 10:10 AM Fink M Kathryn VP, Chief HR Officer Sep 16 '24 Option Exercise 122.51 7,347 900,081 17,389 Sep 17 06:01 PM Fink M Kathryn VP, Chief HR Officer Sep 17 '24 Sale 366.98 7,347 2,696,186 10,042 Sep 17 06:01 PM Fink M Kathryn Officer Sep 17 '24 Proposed Sale 371.19 7,347 2,727,133 Sep 17 04:07 PM